
The systematic review and meta‐analysis aim to explore the available evidence focused on the impact of MBS on improving asthma outcomes via the discontinuation and reduction of asthma medications. After a comprehensive search in the PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases, 15 studies, including pre–post-MBS data on asthma medication use among adults, were eligible for the systematic review. The inference was limited by the small number, variations in follow‐up time and rates, and heterogeneity of studies. Studies that include more ethnically diverse participant samples are needed to improve generalizability.
Like
Save
Share